Chimeric Therapeutics Limited

CHMMF · OTC
Analyze with AI
$0.001+$0.00 (+0%)
At close:Dec 19, 2025, 9:00 PM UTC
$0.001+$0.00 (+0%)
After hours:Dec 19, 2025, 9:00 PM UTC
P/E TTM-0.76
P/B TTM2.57
P/S TTM1.2
Dividend Yield0%
EPS-$0.01
Beta1.556
Valuation
PEG Ratio-0.01
FCF Yield-45.42%
EV / EBITDA-0.70
Quality
ROIC-219.52%
Gross Margin95.36%
Cash Conv. Ratio0.70
Growth
Revenue 3Y CAGR-4.14%
FCF Growth3.48%
Safety
Net Debt / EBITDA0.78
Interest Coverage-176.99
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-2,451.18

Chimeric Therapeutics Limited (CHMMF) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Chimeric Therapeutics Limited (CHMMF) stock price today?

As of Dec 19, 2025, 9:00 PM UTC, Chimeric Therapeutics Limited (CHMMF) stock is trading at $0.001. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CHMMF stock quotes for informed trading decisions.

What is Chimeric Therapeutics Limited's market capitalization?

Chimeric Therapeutics Limited (CHMMF) has a market capitalization of approximately $3.6M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Chimeric Therapeutics Limited's size relative to other companies in the USD market. The market cap figure updates automatically as the CHMMF stock price changes.

What is the 52-week range for Chimeric Therapeutics Limited stock?

Chimeric Therapeutics Limited (CHMMF) stock has traded in a 52-week range of $0.001 — $0.001. The 52-week range shows the highest and lowest prices at which CHMMF traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Chimeric Therapeutics Limited stock price to this range provides context for recent price action.

How much trading volume does Chimeric Therapeutics Limited stock have?

Chimeric Therapeutics Limited (CHMMF) stock recently traded approximately 30K shares. Trading volume indicates market liquidity and investor interest in CHMMF. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Chimeric Therapeutics Limited stock.

Does Chimeric Therapeutics Limited pay dividends to shareholders?

Yes, Chimeric Therapeutics Limited (CHMMF) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Chimeric Therapeutics Limited stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Chimeric Therapeutics Limited's intraday price range?

Today, Chimeric Therapeutics Limited (CHMMF) stock has traded in a range of $0.001 — $0.001. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CHMMF's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Chimeric Therapeutics Limited stock data?

AlphaPilot sources real-time CHMMF stock quotes, fundamental financial data, and historical price charts for Chimeric Therapeutics Limited from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Chimeric Therapeutics Limited stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CHMMF stock performance.